Lawrence E. Morris

4.2k total citations
122 papers, 2.8k citations indexed

About

Lawrence E. Morris is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Lawrence E. Morris has authored 122 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Hematology, 42 papers in Oncology and 27 papers in Immunology. Recurrent topics in Lawrence E. Morris's work include Hematopoietic Stem Cell Transplantation (76 papers), Acute Myeloid Leukemia Research (38 papers) and Acute Lymphoblastic Leukemia research (20 papers). Lawrence E. Morris is often cited by papers focused on Hematopoietic Stem Cell Transplantation (76 papers), Acute Myeloid Leukemia Research (38 papers) and Acute Lymphoblastic Leukemia research (20 papers). Lawrence E. Morris collaborates with scholars based in United States, Netherlands and France. Lawrence E. Morris's co-authors include Asad Bashey, Scott R. Solomon, H. Kent Holland, Stacey Brown, Xu Zhang, Connie A. Sizemore, Melhem Solh, Melissa Sanacore, Karen Manion and Ivana Gojo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lawrence E. Morris

115 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence E. Morris United States	23	2.2k	993	962	572	479	122	2.8k
Richard Champlin United States	19	1.1k 0.5×	251 0.3×	638 0.7×	428 0.7×	332 0.7×	52	1.7k
Qaiser Bashir United States	22	1.4k 0.6×	219 0.2×	745 0.8×	273 0.5×	762 1.6×	182	2.0k
Cristina Gasparetto United States	30	2.0k 0.9×	519 0.5×	1.2k 1.2×	156 0.3×	1.4k 3.0×	128	2.7k
Bart L. Scott United States	35	3.8k 1.8×	366 0.4×	509 0.5×	1.0k 1.8×	1.0k 2.2×	169	4.3k
Yvonne A. Efebera United States	27	1.4k 0.7×	1.4k 1.4×	1.6k 1.6×	80 0.1×	1.0k 2.2×	150	3.0k
Samantha Jaglowski United States	24	992 0.5×	896 0.9×	940 1.0×	241 0.4×	466 1.0×	152	2.9k
Muneer H. Abidi United States	22	1.5k 0.7×	208 0.2×	1.5k 1.6×	150 0.3×	977 2.0×	92	2.7k
Theo M. de Witte Netherlands	19	1.4k 0.6×	721 0.7×	444 0.5×	300 0.5×	409 0.9×	46	2.0k
Radovan Sašo United Kingdom	22	846 0.4×	311 0.3×	384 0.4×	105 0.2×	278 0.6×	50	1.2k
Jeffrey L. Wolf United States	27	1.9k 0.9×	253 0.3×	1.2k 1.3×	168 0.3×	1.5k 3.2×	116	2.6k

Countries citing papers authored by Lawrence E. Morris

Since Specialization

Citations

This map shows the geographic impact of Lawrence E. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence E. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence E. Morris more than expected).

Fields of papers citing papers by Lawrence E. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence E. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence E. Morris. The network helps show where Lawrence E. Morris may publish in the future.

Co-authorship network of co-authors of Lawrence E. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence E. Morris. A scholar is included among the top collaborators of Lawrence E. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence E. Morris. Lawrence E. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baker, Steven Andrew, Asad Bashey, Lizamarie Bachier‐Rodriguez, et al.. (2024). Prophylactic Corticosteroids Allow Safe Outpatient Administration of Axicabtagene Ciloleucel with Comparable Toxicities to Other CAR-T Therapies in Large Cell Lymphoma. Blood. 144(Supplement 1). 2363–2363.

Solomon, Scott R., Lizamarie Bachier‐Rodriguez, Asad Bashey, et al.. (2024). Impact of Graft-Versus-Host Disease on Relapse and Nonrelapse Mortality Following Posttransplant Cyclophosphamide-Based Transplantation. Transplantation and Cellular Therapy. 30(9). 903.e1–903.e9. 1 indexed citations

Solomon, Scott R., Michael T. Aubrey, Lizamarie Bachier‐Rodriguez, et al.. (2024). Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical Transplant. Transplantation and Cellular Therapy. 30(6). 608.e1–608.e10. 1 indexed citations

Patel, Anand, Laura C. Michaelis, Gary J. Schiller, et al.. (2023). PB1889: KB-LANRA 1001: A PHASE 1B/2 STUDY ON SAFETY, PK, PD, AND PRELIMINARY EFFICACY OF THE SELECTIVE SYK INHIBITOR LANRAPLENIB IN COMBINATION WITH THE FLT3 INHIBITOR GILTERITINIB, IN FLT3-MUTATED R/R AML. HemaSphere. 7(S3). e1492994–e1492994. 1 indexed citations

Solh, Melhem, Asad Bashey, Lawrence E. Morris, et al.. (2023). Intrathecal Chemotherapy As Treatment for Chimeric Antigen Receptor T Cell (CAR T) Therapy Associated Neurotoxicity. Blood. 142(Supplement 1). 2138–2138. 1 indexed citations

Solh, Melhem, Asad Bashey, H. Kent Holland, Lawrence E. Morris, & Scott R. Solomon. (2022). Allogeneic Hematopoietic Cell Transplantation (HCT) for Adult Patients with Acute Lymphoblastic Leukemia: Impact of Timely Transplantation on Survival Outcomes. Transplantation and Cellular Therapy. 28(3). S40–S40. 1 indexed citations

Solomon, Scott R., Michael T. Aubrey, Xu Zhang, et al.. (2022). Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group KIR Ligand. Transplantation and Cellular Therapy. 28(9). 601.e1–601.e8. 9 indexed citations

Solh, Melhem, Scott R. Solomon, Asad Bashey, et al.. (2022). Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD). Bone Marrow Transplantation. 58(2). 168–174. 3 indexed citations

O’Donnell, Paul V., Claudio G. Brunstein, Ephraim J. Fuchs, et al.. (2021). Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes. Transplantation and Cellular Therapy. 28(2). 109.e1–109.e8. 10 indexed citations

10.

Fuchs, Ephraim J., Paul V. O’Donnell, Mary Eapen, et al.. (2020). Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. Blood. 137(3). 420–428. 106 indexed citations

11.

Solomon, Scott R., Melhem Solh, Xu Zhang, et al.. (2019). Fludarabine and Total-Body Irradiation Conditioning before Ablative Haploidentical Transplantation: Long-Term Safety and Efficacy. Biology of Blood and Marrow Transplantation. 25(11). 2211–2216. 12 indexed citations

12.

Solh, Melhem, Xu Zhang, Stacey Brown, et al.. (2016). Factors Predicting Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single Center. Biology of Blood and Marrow Transplantation. 22(8). 1403–1409. 38 indexed citations

13.

Solomon, Scott R., Melissa Sanacore, Xu Zhang, et al.. (2014). Calcineurin Inhibitor–Free Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peripheral Blood Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(11). 1828–1834. 41 indexed citations

14.

Bashey, Asad, Xu Zhang, Connie A. Sizemore, et al.. (2013). T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation. Journal of Clinical Oncology. 31(10). 1310–1316. 333 indexed citations

15.

Solomon, Scott R., Stephanie Jacobson, Melissa Sanacore, et al.. (2013). Myeloablative Conditioning With PBSC Grafts For T-Replete Haploidentical Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide Results In Universal Engraftment, Low Rates Of Gvhd, NRM and Excellent Survival Outcomes: An Analysis Of Two Consecutive Phase II Studies From a Single Center. Blood. 122(21). 3351–3351. 3 indexed citations

16.

Solomon, Scott R., Connie A. Sizemore, Melissa Sanacore, et al.. (2012). Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial. Biology of Blood and Marrow Transplantation. 18(12). 1859–1866. 207 indexed citations

17.

Gore, Steven D., Ivana Gojo, Mikkael A. Sekeres, et al.. (2010). Single Cycle of Arsenic Trioxide–Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia. Journal of Clinical Oncology. 28(6). 1047–1053. 69 indexed citations

18.

Solomon, Scott R., et al.. (2009). Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM. Bone Marrow Transplantation. 45(3). 468–475. 31 indexed citations

19.

Vogelsang, Georgia B. & Lawrence E. Morris. (1993). Prevention and Management of Graft-versus-Host Disease. Drugs. 45(5). 668–676. 7 indexed citations

20.

Hess, Allan D., Richard J. Jones, Lawrence E. Morris, et al.. (1992). Autologous graft-versus-host disease: A novel approach for antitumor immunotherapy. Human Immunology. 34(3). 219–224. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact